CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies
Authors:
- Sheng WeiSWSheng Wei
- Qingyi WeiQWQingyi Wei
Open Access
- 22 February 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 31 (5) , 850-857
Abstract
Several potentially functional polymorphisms of CASP8 encoding an apoptotic enzyme, caspase 8, have been implicated in cancer risk, but individually published studies showed inconclusive results. We performed a meta-analysis of 23 publications with a total of 55 174 cancer cases and 59 336 controls from 55 individual studies. We summarized the data on the associations between three studied CASP8 polymorphisms (G>C D302H, –652 6N del and Ex14-271A>T ) and cancer risk and performed subgroup analysis by ethnicity, cancer type, study design and etiology. We found that D302H CC and CG variant genotypes were associated with significantly reduced overall risk of cancers using conservative random genetic models [homozygote comparison: odds ratios (OR) = 0.79; 95% confidence interval (CI): 0.69–0.92; dominant comparison: OR = 0.93, 95% CI: 0.89–0.98; recessive comparison: OR = 0.81, 95% CI: 0.71–0.93). In further stratified analyses, the reduced cancer risk remained for subgroups of Caucasians, breast or estrogen-related cancers, and hospital- or population-based studies, except for an elevated risk for brain tumors. Similarly, the –652 6N del polymorphism was also associated with significantly reduced overall risk of cancers (homozygote comparison: OR = 0.84, 95% CI: 0.75–0.94; dominant comparison: OR = 0.88, 95% CI: 0.81–0.96; recessive comparison: OR = 0.90, 95% CI: 0.82–0.99) and all subgroups analyzed. However, the Ex14-271A>T polymorphism did not appear to have an effect on cancer risk. These results suggest that CASP8 D302H and –652 6N del polymorphisms are potential biomarkers for cancer risk.Keywords
This publication has 49 references indexed in Scilit:
- A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancersNature Genetics, 2007
- Mechanism of estrogen-induced apoptosis in breast cancer cells: Role of the NF-κB signaling pathwayBiochemistry (Moscow), 2007
- A common coding variant in CASP8 is associated with breast cancer riskNature Genetics, 2007
- CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiformeCarcinogenesis, 2007
- Caspases in cell survival, proliferation and differentiationCell Death & Differentiation, 2006
- Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphomaCarcinogenesis, 2006
- Polymorphisms in the caspase-8 gene and the risk of lung cancerCancer Genetics and Cytogenetics, 2006
- Loss of Caspase-8 in Tumor Cells: Mechanism to Overcome Integrin-Mediated Death?Molecular Interventions, 2006
- Re: Association of a Common Variant of the CASP8 Gene With Reduced Risk of Breast CancerJNCI: Journal of the National Cancer Institute, 2005
- Overview of the Epidemiology of Pancreatic Cancer Focusing on the JACC StudyJournal of Epidemiology, 2005